Howard Bailey
Director and Associate Dean of Oncology at the Carbone Cancer Center · University of Wisconsin Hospitals and Clinics
Credentials: · ·
History
- Present
Oncology at the Carbone Cancer Center · University of Wisconsin Hospitals and Clinics
- 1988–1989
UW Comprehensive Cancer Center
Research
Journal of Biological Chemistry · 1997 · 412 citations
Enhancing the bioavailability of resveratrol by combining it with piperine
Molecular Nutrition & Food Research · 2011 · 232 citations
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors
New England Journal of Medicine · 2023 · 219 citations
- GW
29 papers
15 papers
8 papers · 4 as a fellow
- HP
8 papers
7 papers
- AT
6 papers
6 papers
- WS
6 papers
Grants
- 1997–2028
UW Comprehensive Cancer Center Support
National Cancer Institute · P30
Contact PI · $60.1M · University of Wisconsin-Madison
- 2020–2025
The MW Cancer Prevention Clinical Trials Network
National Cancer Institute · UG1
Contact PI · $4.2M · University of Wisconsin-Madison
- 2014–2023
Other Functions - Cancer Prevention Agent Development Program: Early Phase Clinical Research
National Cancer Institute · N01
Contact PI · $12.1M · University of Tx Md Anderson Can Ctr
- 2003–2014
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
National Cancer Institute · N01
Contact PI · $3.3M · University of Wisconsin-Madison
Clinical trials
- 2011–2012
Resveratrol With or Without Piperine to Enhance Plasma Levels of Resveratrol
Principal investigator · Completed
University of Wisconsin, Madison
- 2008–2010
Study of 9cUAB30 in Healthy Participants
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
- 2005–2010
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
- 2003–2007
Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients
Principal investigator · Completed · Phase 2
University of Wisconsin, Madison